Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Total Operating Expense | 1.02 | 1.31 | -1.91 | 0.44 |
Net Income After Taxes | -0.29 | -0.13 | 2.02 | -0.44 |
Income Availableto Com Incl Extra Ord | -0.29 | -0.13 | 2.02 | -0.44 |
Costof Revenue Total | 0.70 | 1.13 | - | - |
Gross Profit | 0.02 | 0.05 | - | - |
Diluted Weighted Average Shares | 1.01 | 1.00 | 1.00 | 1.00 |
Diluted Net Income | -0.29 | -0.13 | 2.02 | -0.44 |
Provisionfor Income Taxes | 0.00 | 0.00 | 0.05 | 0.00 |
period Type | - | - | - | - |
Net Income Before Extra Items | -0.29 | -0.13 | 2.02 | -0.44 |
Total Revenue | 0.73 | 1.18 | 0.15 | 0.00 |
Operating Income | -0.29 | -0.13 | 2.06 | -0.44 |
Net Income | -0.29 | -0.13 | 2.02 | -0.44 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Revenue | 0.73 | 1.18 | 0.15 | 0.00 |
Income Availableto Com Excl Extra Ord | -0.29 | -0.13 | 2.02 | -0.44 |
Selling/ General/ Admin Expenses Total | 0.06 | 0.05 | 0.05 | 0.05 |
Other Operating Expenses Total | 0.26 | 0.14 | 0.64 | 0.39 |
Net Income Before Taxes | -0.29 | -0.13 | 2.06 | -0.44 |
Diluted Normalized EPS | -0.29 | -0.13 | 0.32 | -0.44 |
Diluted EPS Excluding Extra Ord Items | -0.29 | -0.13 | 2.02 | -0.44 |
Unusual Expense( Income) | - | 0.00 | -2.60 | 0.00 |
Roselabs Finance Dividend Roselabs Finance Bonus Roselabs Finance News Roselabs Finance AGM Roselabs Finance Rights Roselabs Finance Splits Roselabs Finance Board Meetings Roselabs Finance Key Metrics Roselabs Finance Shareholdings Roselabs Finance Balance Sheet Roselabs Finance Cashflow Roselabs Finance Q1 Results Roselabs Finance Q2 Results Roselabs Finance Q3 Results Roselabs Finance Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks